share_log

Forte Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED(9.99%),TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED(9.99%), etc.

Forte Biosciences | SC 13G:超過5%持股股東披露文件-TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED(9.99%),TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED(9.99%)等

美股sec公告 ·  02/14 17:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息